Shares of Obalon Therapeutics hovering around issue price in market debut

Shares of Obalon Therapeutics , a medical device company, were trading at $15.20 Thursday, above the company’s $15 issue price in its market debut. The company sold 5 million shares to raise $750 million. UBS Investment Bank, Canaccord Genuity and Stifel were the lead underwriters on the offering.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Leave a Reply